Quidel | QDEL - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 25.51B 488M 2026-03
Agilent USD 4.76B 148M 2026-03
Avanos Medical USD 325M 30.4M 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Bruker USD 2.1B 108.9M 2026-03
Cerus USD 174.38M 7.26M 2025-12
Charles River Laboratories USD 1.49B 41.76M 2026-03
Danaher USD 13.38B 554M 2026-06
Haemonetics USD 834.88M 108.8M 2026-03
Illumina USD 2.74B 551M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Merit Medical Systems USD 1.1B 61.62M 2026-03
Mettler Toledo International USD 1.33B 30.76M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
Neogen USD 590M 15.42M 2025-12
OraSure Technologies USD 240.78M 21.13M 2026-03
Pacific Biosciences Of California USD 369.52M 5.54M 2026-03
Quidel USD 1.38B 70.3M 2026-03
Revvity USD 2.13B 111.43M 2026-03
STAAR Surgical USD 312.4M 853K 2026-03
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Waters USD 3.72B 1.73B 2026-03